Featured Opinions
Adherence Arena: What is the real cost of non-adherence?
The higher the rate of non-adherence, the greater our sense of urgency should be
Mal’s Musings: Why Google Health is a step too far
The social media revolution may be great, but it's not always right when it comes to healthcare
5 tips for successful patient outreach
by Anonymous (not verified)
As patients increasingly drive their own medical care, the value of direct, two-way conversation between biopharma and patients also increases.
Pharma DTC at the Crossroads? 2011 Prevention DTC Study Results
Here are six thought starters I see coming out of Prevention Magazine’s 14th Annual Pharmaceutical Direct-to-Consumer (DTC) Advertising Study.*
Patients, orphan drugs and pricing controversies
by EileenOBrien
What the Makena backlash means for the rare disease community
M’s the Word: Running, for life
Why competition is healthy when harnessed to a good cause
Pharma companies moving digital mainstream - EMEA survey among 200 pharmaceutical executives
by Anonymous (not verified)
Pharma companies moving digital mainstream
New pharma business models: What marketers and reps need to know
To succeed in the new pharma landscape, marketers and reps need to learn, and unlearn, a lot
Why pharma needs to boost its business acumen
by Steven Rosen
Want to improve sales? Improve sales managers' business planning skills
Rough Clay: Don’t like change? You’ll like irrelevance even less
Pharma desperately needs new ideas, but first it needs new language in which to think about them
Dr. Bates’ Talkback: How to get more value from existing products
How to identify and support top-performing products
What are pharma sales reps for?
by Anonymous (not verified)
If you think your mission is value communication, think again
Patient power: From technology to treatments
How self-tracking systems can improve clinical trials
M’s the Word: Prepare for the unexpected
How randomness, rather than technological targeting, makes life interesting
Monthly newsletter: Patients, marketing, and the long-tail search
by Wendy White
Offering education to rare disease patients through long-tail ads is a win-win for audiences and marketer
Ms the word: The lost art of letter writing
Delete that email! Put it down on paper, instead.
Pharma marketing and social media: Dont wait for the FDA
by EileenOBrien
*Even in the absence of FDA social media guidelines, there is still a lot pharma marketers can do*
Ms the Word: Pressure testing presentations
How working under pressure brings out the best in us
Ms the word: Why we do what we do
Even marketing people can occasionally accomplish good